Mesenchymal Stem Cell-based Therapy for COVID-19: Possibility and Potential.

In this study, we summarized the clinical outcomes of MSCs for ARDS patients in some preclinical and clinical studies, and discussed the application of MSCs for patients with COVID-19 in China and the related important issues with MSCs use during the outbreak. PMID: 32479246 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32479246?dopt=Abstract

Source: Current Stem Cell Research and Therapy - May 31, 2020 Category: Stem Cells Authors: Xiong J, Bao L, Qi H, Feng Z, Shi Y Tags: Curr Stem Cell Res Ther Source Type: research